Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Targeted Anticancer Therapies Congress 2026

Start date: 16 Mar 2026
End date: 18 Mar 2026
Location: Paris, France

Plan your participation in the ESMO Targeted Anticancer Therapies Congress 2026, taking place from 16 to 18 March 2026 in Paris, France.

The journey of innovation in cancer treatment begins with early drug development. ESMO TAT serves as a dynamic, multi-stakeholder forum, uniting researchers, industry leaders, investors, regulators, and patient advocates under one roof to accelerate the delivery of life-changing anticancer therapies to patients.

Join us in the pursuit to advance cancer treatment: we look forward to seeing you at this transformative event, to share new data, foster collaboration, and tackle challenges that will drive early clinical development forward.

Innovate. Collaborate. Advance.